title: [Acute lymphoblastic leukemia in childhood treated with non-T-cell depleted bone marrow transplantation from an HLA 2 loci (HLA-A and-DRB1)-mismatched mother after early graft failure of cord blood transplantation].
abstract: An 11-year-old boy with acute lymphoblastic leukemia received unrelated cord blood transplantation at the second remission. Because of early graft failure, he was given a second non-T-cell depleted bone marrow transplant from his HLA 2 loci (HLA-A and -DRB1)-mismatched mother 36 days after the first transplantation. Feto-maternal microchimerism was verified before transplantation. The second transplantation was performed with fludarabine/melphalan as a conditioning regimen, and tacrolimus/short-course methotrexate as graft-versus-host disease (GVHD) prophylaxis. Engraftment was prompt with a recovery of neutrophils (> 0.5 x 10(9)/1) by day +10, reticulocytes (> 1%) by day +17 and platelets (> 50 x 10(9)/l) by day +18. Mild regimen-related toxicities (grade I gastrointestinal, grade II hepatic) were observed and acute GVHD was grade I (skin: stage 2). No severe complication was noted. At 6 months post-transplantation, he had no chronic GVHD or leukemia relapse. This experience indicates the future feasibility of a back-up non-T-cell depleted transplantation from HLA 2 loci-mismatched and feto-maternal microchimerism-positive mothers in cases with primary graft failure.
authors.affiliation: Department of Pediatrics, Matsushita Memorial Hospital.
authors.forename: Hiroyuki
authors.initials: H
authors.lastname: Ishida
authors.forename: Kanako
authors.initials: K
authors.lastname: Mori
authors.forename: Takao
authors.initials: T
authors.lastname: Yoshihara
authors.forename: Noriko
authors.initials: N
authors.lastname: Shin
authors.forename: Akira
authors.initials: A
authors.lastname: Morimoto
authors.forename: Shinsaku
authors.initials: S
authors.lastname: Imashuku
mesh_terms: D016026:Bone Marrow Transplantation / Q000379:methods*; D002648:Child; D005260:Female; D006086:Graft vs Host Disease / Q000517:prevention & control; D015234:HLA-A Antigens / Q000276:immunology*; D006684:HLA-DR Antigens / Q000276:immunology* / Q000528:radiation effects; D059811:HLA-DRB1 Chains; D006648:Histocompatibility / Q000502:physiology; D006801:Humans; D008297:Male; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000628:therapy*
chemical_list: D015234:HLA-A Antigens; D006684:HLA-DR Antigens; D059811:HLA-DRB1 Chains